
S1EP13 Pressing Forward: The Peer-Reviewed Path of Fenbendazole in Cancer Research
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Got Questions? Send us a message!
Join us on "Fenben Voices" to uncover "Pressing Forward: The Peer-Reviewed Path of Fenbendazole in Cancer Research." We unravel a new study that highlights the combined use of fenbendazole with other antiparasitics in cancer treatment. This episode examines the rigorous research backing and the broader implications for oncology. Listen as we explore:
- Overview of Recent Study: Details of the peer-reviewed research combining fenbendazole with ivermectin and mebendazole.
- Impact of Combined Treatment: Analysis of how these drugs work together to combat cancer more effectively.
- Scientific Endorsement and Credibility: Discussion on the importance of peer review and validation in cancer research.
- Implications for Future Treatments: How this study could influence future cancer therapies and patient care.
- Calls to Action for Oncology: Urging further research and consideration by the medical community.
FenbendazoleHelp.org is an informational resource provided by the Fenben Foundation. The Fenben Foundation and its informational resources are not intended to provide personal medical advice. Always consult your physician before beginning any protocols. No information on this site is intended to diagnose, treat, or otherwise replace the opinion of medical professionals. The purpose of this site is for informational purposes ONLY.